A systematic review and meta-analysis of HIV transmission risk behaviors, genetic variations, and antiretroviral (ARV) resistance in LGBT populations
DR Sulistina, S Martini, B Prasetyo… - Journal of Public …, 2024 - journals.sagepub.com
Background: Currently, human immunodeficiency virus and acquired immunodeficiency
syndrome (HIV/AIDS) has become one of the major health problems worldwide, including …
syndrome (HIV/AIDS) has become one of the major health problems worldwide, including …
Why is there so much controversy regarding the population health impact of the great recession? Reflections on three case studies
In the aftermath of the Great Recession, public health scholars have grown increasingly
interested in studying the health consequences of macroeconomic change. Reflecting …
interested in studying the health consequences of macroeconomic change. Reflecting …
Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya
HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-
Saharan Africa with the rollout of antiretroviral (ARV) therapy. Such data are, however …
Saharan Africa with the rollout of antiretroviral (ARV) therapy. Such data are, however …
Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003–2015: Transmitted drug resistance is due to onward transmissions
Background The prevalence of HIV-1 drug resistance among treatment-naïve patients
ranges between 8.3% and 15% in Europe and North America. Previous studies showed that …
ranges between 8.3% and 15% in Europe and North America. Previous studies showed that …
Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis
SJ Snedecor, L Sudharshan, K Nedrow… - AIDS Research and …, 2014 - liebertpub.com
The prevalence of HIV drug resistance varies with geographic location, year, and treatment
exposure. This study generated yearly estimates of nonnucleoside reverse transcriptase …
exposure. This study generated yearly estimates of nonnucleoside reverse transcriptase …
Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity
I Alexiev, A Shankar, AMJ Wensing… - Journal of …, 2015 - academic.oup.com
Objectives To determine transmitted drug resistance (TDR) and HIV-1 genetic diversity in
Bulgaria. Methods The prevalence of TDR and HIV-1 subtypes was determined in 305/1446 …
Bulgaria. Methods The prevalence of TDR and HIV-1 subtypes was determined in 305/1446 …
HIV-1 infection in Cyprus, the Eastern Mediterranean European frontier: a densely sampled transmission dynamics analysis from 1986 to 2012
AC Pineda-Peña, K Theys, DC Stylianou… - Scientific Reports, 2018 - nature.com
Since HIV-1 treatment is increasingly considered an effective preventionstrategy, it is
important to study local HIV-1 epidemics to formulate tailored preventionpolicies. The …
important to study local HIV-1 epidemics to formulate tailored preventionpolicies. The …
Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance
M Stanojevic, M Siljic, D Salemovic… - AIDS research and …, 2014 - liebertpub.com
In Serbia, the first cases of HIV infection were reported in 1985, whereas antiretroviral (ARV)
therapy has been in use since 1987. With this study we aimed to assess the occurrence and …
therapy has been in use since 1987. With this study we aimed to assess the occurrence and …
molecular epidemiology of HIV type 1 infection in northern Greece (2009–2010): evidence of a transmission cluster of HIV type 1 subtype A1 drug-resistant strains …
ZA Antoniadou, I Kousiappa, L Skoura… - AIDS research and …, 2014 - liebertpub.com
A prospective molecular epidemiology study of HIV-1 infection was conducted in newly
diagnosed and antiretroviral-naive patients in Northern Greece between 2009 and 2010 …
diagnosed and antiretroviral-naive patients in Northern Greece between 2009 and 2010 …
Prevalence of transmitted drug resistance mutations in HIV-1-infected drug-naive patients from urban and suburban regions of Kenya
HIV was first described in Kenya in 1984–1985. Currently, Kenya has an estimated HIV-1
prevalence of 6.2%. With the introduction of antiretroviral drugs, the survival of most HIV …
prevalence of 6.2%. With the introduction of antiretroviral drugs, the survival of most HIV …